#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study of Pertuzumab and Trastuzumab for Patients with Solid Malignant Tumors from Previous Pertuzumab Trials

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Portugal Spain

  • Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Belgium Czechia Denmark France Germany Hungary +4

  • Study on the Safety and Effectiveness of BI 3720931 for Adults with Cystic Fibrosis Who Cannot Use CFTR Modulators

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France Italy The Netherlands Spain

  • Study of Letetresgene Autoleucel for Patients with Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France Italy The Netherlands Spain

  • Long-Term Study of Tofacitinib for Children and Teens with Juvenile Idiopathic Arthritis

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Poland Spain

  • Long-Term Safety Study of BI 3720931 for Patients with Cystic Fibrosis from a Previous Trial

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France Italy The Netherlands Spain

  • Study of SKB264 for Patients with Advanced Solid Tumors Not Responding to Standard Treatments

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Spain

  • Study of ASP1570 Alone or with Pembrolizumab for Adults with Advanced Solid Tumors

    Not recruiting

    1 1 1
    Investigated drugs:
    France Spain

  • Study of Eltrekibart for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    1
    Investigated diseases:
    Investigated drugs:
    Germany Greece Poland

  • Study on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria France Germany Italy The Netherlands Poland +2